Document Detail

Red cell distribution width (RDW) as a marker of disease activity in patients with hairy cell leukemia.
MedLine Citation:
PMID:  9588069     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Increased RDW in HCL is associated with active disease and is reversible after successful therapy. This phenomenon has not been reported in the literature yet. Preliminary results show that the increase of RDW may be due to the dyserythropoiesis.
L Chrobák; P Zák; K Podzimek; P Stránský
Related Documents :
24848439 - Effective knock down of matrix metalloproteinase-13 by an intra-articular injection of ...
11919449 - Choroid plexectomy reduces neurosurgical intervention in patients with hydranencephaly.
2104939 - Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical t...
10627639 - Intravesical rhgm-csf for the treatment of late onset hemorrhagic cystitis after bone m...
9552059 - Demyelination and single-carbon transfer pathway metabolites during the treatment of ac...
8808719 - Recombinant human granulocyte-macrophage colony-stimulating factor (rhugm-csf) in leuko...
20375729 - Tailoring treatment duration to 12 to 16 weeks in hepatitis c genotype 2 or 3 with rapi...
17508239 - Similar success rates with bivalirudin and unfractionated heparin in bare-metal stent i...
20108569 - Ahmed and baerveldt glaucoma drainage implants: long-term results and factors influenci...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové     Volume:  41     ISSN:  1211-4286     ISO Abbreviation:  Acta Medica (Hradec Kralove)     Publication Date:  1998  
Date Detail:
Created Date:  1998-06-16     Completed Date:  1998-06-16     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9705947     Medline TA:  Acta Medica (Hradec Kralove)     Country:  CZECH REPUBLIC    
Other Details:
Languages:  eng     Pagination:  23-6     Citation Subset:  IM    
Department of Clinical Hematology, Charles University, Faculty of Medicine and Teaching Hospital, Hradec Králové.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
2-Chloroadenosine / analogs & derivatives,  therapeutic use
Aged, 80 and over
Antineoplastic Agents / therapeutic use
Deoxyadenosines / therapeutic use
Erythrocyte Indices*
Hemoglobins / analysis
Interferon-alpha / therapeutic use
Leukemia, Hairy Cell / blood*,  therapy
Middle Aged
Remission Induction
Reg. No./Substance:
0/Antineoplastic Agents; 0/Deoxyadenosines; 0/Hemoglobins; 0/Interferon-alpha; 115044-75-2/2-chloro-3'-deoxyadenosine; 146-77-0/2-Chloroadenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A comparison of the therapeutic efficacy of conventional and modern oximes against supralethal doses...
Next Document:  Mean blood pressure and velocity for calculation of ventricular systolic work.